| AAT | Alpha 1-antitrypsin |
| AATD | Alpha 1-antitrypsin deficiency |
| PN | Proteostasis network |
| ER | Endoplasmic reticulum |
| ERAD | ER-associated degradation |
| NSPs | Neutrophil serine proteases |
| RCL | Reactive center loop |
| PAS + D | Periodic acid–Schiff-positive diastase |
| GS1 and GS2 | Glucosidase I and II |
| CNX | Calnexin |
| ERGIC53 | Endoplasmic reticulum–Golgi intermediate compartment |
| ERp57 | Calnexin–endoplasmic reticulum protein 57 |
| GRP94 | Glucose-regulated protein 94 |
| UGGT1 | Uridine diphosphate (UDP)-glucose:glycoprotein glucosyltransferase 1 |
| ERManI | ER α-mannosidase I |
| EDEM | ER degradation-enhancing α-mannosidase-like proteins |
| HRD1 | HMG-CoA reductase degradation 1 homolog |
| HERPUD1 | Homocysteine inducible ER protein with ubiquitin-like domain 1 |
| UPS | Ubiquitin–proteasome system |
| DUBs enzyme | Deubiquitinilating enzyme |
| CBZ | Carbamazepine |
| TFEB | Transcription factor EB master gene |
| ERLAD | ER-to-lysosome-associated degradation |
| UPR | Unfolded protein response |
| CF | Cystic fibrosis |
| CFTR | Cystic fibrosis transmembrane conductance regulator |
| 4-PBA | Sodium 4-phenylbutyrate |
| SAHA | Suberoylanilide hydroxamic acid |